Apoptotic versus proliferative activities in human benign prostatic hyperplasia

Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.

Yael Gavrieli, Yoav Sherman, Shmuel A. Ben‐Sasson · The Journal of Cell Biology · 1992 · 9.5K citations · Full text

Dna Damage, Apoptosis, Dna Analysis +16

The Development of Human Benign Prostatic Hyperplasia with Age

Stephen J. Berry, Donald S. Coffey, Patrick C. Walsh et al. · The Journal of Urology · 1984 · 2.5K citations

Monoclonal antibodies against recombinant parts of the Ki‐67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave‐processed formalin‐fixed paraffin sections

Giorgio Cattoretti, Michael H. G. Becker, Göran Key et al. · The Journal of Pathology · 1992 · 1.5K citations

BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death.

David M. Hockenbery, Mary M. Zutter, William F. Hickey et al. · Proceedings of the National Academy of Sciences · 1991 · 1.3K citations

Bcl2 Protooncogene, Signal Transduction, Developmental Biology +15

Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer.

Timothy J. McDonnell, Patricia Troncoso, Shawn Brisbay et al. · PubMed · 1992 · 1.1K citations

Urology, Endocrine-related Cancer, Genitourinary Cancer +13